Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | CVP,PRES-ORTHO & TISSUE TECH | October 07, 2016 | October 11, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date October 07, 2016 · Filed October 11, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,962 |
Reported balance
After 2016-10-07 transaction · row 1
1 source rowRow 1 · 2016-10-07 · Tax withholding · Disposed 272 · Balance 7,962 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Conformis Inc
Report date September 05, 2023 · Filed September 05, 2023
Section 16 reporting ended · disclosed 2023-09-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2023-09-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-09-05 · Grant · Acquired 17,778 · Balance 190,277 F1: Represents receipt of Common Stock upon settlement of performance-based vesting restricted stock units granted on July 27, 2021. Row 2 · 2023-09-05 · Disposition to issuer · Disposed 190,277 · Balance 0 F2: The reported securities were disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of June 22, 2023, by and among Issuer, restor3d, Inc., a Delaware corporation ("restor3d"), and Cona Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of restor3d ("Merger Sub"). Immediately prior to effectiveness of the merger, each outstanding share of restricted stock vested in full. Upon effectiveness of the merger, in exchange for each share of Common Stock, the reporting person received $2.27 in cash, without interest and less applicable withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents receipt of Common Stock upon settlement of performance-based vesting restricted stock units granted on July 27, 2021.
F2: The reported securities were disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of June 22, 2023, by and among Issuer, restor3d, Inc., a Delaware corporation ("restor3d"), and Cona Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of restor3d ("Merger Sub"). Immediately prior to effectiveness of the merger, each outstanding share of restricted stock vested in full. Upon effectiveness of the merger, in exchange for each share of Common Stock, the reporting person received $2.27 in cash, without interest and less applicable withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 05, 2023 Filed Sep 5, 2023 06:13 UTC | Conformis Inc CFMS · Entity 109987 | Disposition to issuerCommon Stock | 190,277 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-23-042500 · form4.xml · nonDerivative · entry 2 Augusti Mark A · CIK 0001481783 · Director · FORMER PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · price: The reported securities were disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of June 22, 2023, by and among Issuer, restor3d, Inc., a Delaware corporation ("restor3d"), and Cona Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of restor3d ("Merger Sub"). Immediately prior to effectiveness of the merger, each outstanding share of restricted stock vested in full. Upon effectiveness of the merger, in exchange for each share of Common Stock, the reporting person received $2.27 in cash, without interest and less applicable withholding taxes. Read SEC document |
| September 05, 2023 Filed Sep 5, 2023 06:13 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock | 17,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-042500 · form4.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · FORMER PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,277 F1 · price: Represents receipt of Common Stock upon settlement of performance-based vesting restricted stock units granted on July 27, 2021. Read SEC document |
| April 25, 2023 Filed May 11, 2023 17:06 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock | 75,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001305773-23-000024 · wf-form4_168383916996800.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,508,876 F1 · shares: Represents a grant of shares of restricted stock, which vests in 25% increments on each of the first, second, third and fourth anniversaries of the date of grant. Read SEC document |
| May 24, 2022 Filed May 26, 2022 12:46 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock · Derivative | 1,538,136 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001305773-22-000067 · wf-form4_165358355029492.xml · derivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,538,136 Underlying: Common Stock · 1,538,136 shares Expires 2032-05-24 F1 · shares: Represents the number of options granted to the Reporting Person pursuant to Conformis' 2015 Stock Incentive Plan. The shares will vest as follows: 25% annually over a 48 month period, beginning 5/24/2023. Read SEC document |
| May 07, 2022 Filed May 10, 2022 16:37 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 22,396 | $0.46 | $10,279.76 |
DisclosureSEC source: 0001305773-22-000061 · wf-form4_165221500665544.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,433,726 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 18:30 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 25,249 | $0.74 | $18,797.88 |
DisclosureSEC source: 0001305773-22-000004 · wf-form4_164133901344442.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,456,122 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.7444-$0.7483, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 03, 2021 Filed Nov 4, 2021 17:00 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 40,000 | $1.20 | $48,000.00 |
DisclosureSEC source: 0001305773-21-000128 · wf-form4_163605961992446.xml · nonDerivative · entry 2 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,481,371 F2 · shares: This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 17:00 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 49,953 | $1.20 | $59,943.60 |
DisclosureSEC source: 0001305773-21-000128 · wf-form4_163605961992446.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,521,371 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 17:37 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 5,000 | $1.40 | $7,000.00 |
DisclosureSEC source: 0001305773-21-000104 · wf-form4_162871784195535.xml · nonDerivative · entry 2 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,571,324 F2 · shares: This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 17:37 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 7,493 | $1.42 | $10,640.06 |
DisclosureSEC source: 0001305773-21-000104 · wf-form4_162871784195535.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,576,324 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 17:35 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock | 444,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001305773-21-000072 · wf-form4_162318812734888.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,583,817 Read SEC document |
| May 18, 2021 Filed May 18, 2021 21:21 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 4,781 | $0.81 | $3,872.61 |
DisclosureSEC source: 0001305773-21-000050 · wf-form4_162138725635757.xml · nonDerivative · entry 3 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,139,373 F4 · shares: This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Read SEC document |
| May 17, 2021 Filed May 18, 2021 21:21 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 7,311 | $0.80 | $5,812.25 |
DisclosureSEC source: 0001305773-21-000050 · wf-form4_162138725635757.xml · nonDerivative · entry 2 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,144,154 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F3 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.7950-$0.8000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 14, 2021 Filed May 18, 2021 21:21 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 54,552 | $0.76 | $41,519.53 |
DisclosureSEC source: 0001305773-21-000050 · wf-form4_162138725635757.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,151,465 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.7600-$0.7892, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 10, 2021 Filed May 11, 2021 18:16 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 16,600 | $0.99 | $16,355.98 |
DisclosureSEC source: 0001305773-21-000044 · wf-form4_162077139102068.xml · nonDerivative · entry 2 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,206,017 F3 · shares: This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F4 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.9068-$1.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 07, 2021 Filed May 11, 2021 18:16 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 25,468 | $0.80 | $20,376.95 |
DisclosureSEC source: 0001305773-21-000044 · wf-form4_162077139102068.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,222,617 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.8000-$0.8103, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 05, 2021 Filed Jan 6, 2021 19:42 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 32,260 | $0.75 | $24,127.25 |
DisclosureSEC source: 0001305773-21-000003 · wf-form4_160998015904849.xml · nonDerivative · entry 2 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,248,085 F3 · shares: This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F4 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.71350-$0.78500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 19:42 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 61,025 | $0.64 | $39,159.74 |
DisclosureSEC source: 0001305773-21-000003 · wf-form4_160998015904849.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,280,345 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.64000-$0.64610, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 03, 2020 Filed Dec 4, 2020 16:41 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 2,238 | $0.65 | $1,454.70 |
DisclosureSEC source: 0001305773-20-000112 · wf-form4_160711810067900.xml · nonDerivative · entry 2 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,341,370 F3 · shares: This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 16:41 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 3,462 | $0.65 | $2,239.91 |
DisclosureSEC source: 0001305773-20-000112 · wf-form4_160711810067900.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343,608 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.64700-$0.65000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 03, 2020 Filed Nov 4, 2020 20:36 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 40,000 | $0.66 | $26,460.00 |
DisclosureSEC source: 0001305773-20-000107 · wf-form4_160454019139415.xml · nonDerivative · entry 2 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,347,070 F3 · shares: This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F4 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.6500-$0.6851, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 20:36 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 64,065 | $0.65 | $41,847.26 |
DisclosureSEC source: 0001305773-20-000107 · wf-form4_160454019139415.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,387,070 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.6033-$0.6550, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 18:14 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 7,927 | $0.70 | $5,548.90 |
DisclosureSEC source: 0001305773-20-000093 · wf-form4_159727047455031.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,451,135 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. Read SEC document |
| July 02, 2020 Filed Jul 2, 2020 19:59 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 26,280 | $0.75 | $19,754.68 |
DisclosureSEC source: 0001305773-20-000076 · wf-form4_159373435394978.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,459,062 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.7500-$0.7815, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 15, 2020 Filed May 18, 2020 18:21 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 7,294 | $0.95 | $6,929.30 |
DisclosureSEC source: 0001305773-20-000063 · wf-form4_158984049638243.xml · nonDerivative · entry 2 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,485,342 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.950000-$0.959850, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 14, 2020 Filed May 18, 2020 18:21 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock | 693,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001305773-20-000063 · wf-form4_158984049638243.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,492,636 Read SEC document |
| May 07, 2020 Filed May 8, 2020 17:47 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 26,187 | $0.95 | $24,877.65 |
DisclosureSEC source: 0001305773-20-000048 · wf-form4_158897441476666.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,799,303 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.950000-$0.950500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 03, 2020 Filed Jan 6, 2020 17:44 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 56,699 | $1.42 | $80,336.81 |
DisclosureSEC source: 0001305773-20-000003 · wf-form4_157835067041887.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,825,490 F1 · shares: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.4100-$1.4406, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 07:42 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 3,353 | $1.86 | $6,236.58 |
DisclosureSEC source: 0001305773-19-000127 · wf-form4_157546335833261.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,882,189 F1 · kind: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. Read SEC document |
| November 02, 2019 Filed Nov 22, 2019 17:56 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock | 800,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001305773-19-000121 · wf-form4_157446334549072.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,885,542 Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 16:44 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 7,489 | $1.66 | $12,431.74 |
DisclosureSEC source: 0001305773-19-000096 · wf-form4_156538346129031.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085,542 F1 · kind: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 08:36 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 23,860 | $4.15 | $99,019.00 |
DisclosureSEC source: 0001305773-19-000077 · wf-form4_156215739406884.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,093,031 F1 · kind: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. Read SEC document |
| May 16, 2019 Filed May 17, 2019 18:02 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 6,807 | $3.53 | $24,028.71 |
DisclosureSEC source: 0001305773-19-000071 · wf-form4_155813052294991.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,116,891 F1 · kind: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. Read SEC document |
| May 07, 2019 Filed May 8, 2019 18:45 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 25,477 | $2.72 | $69,335.66 |
DisclosureSEC source: 0001305773-19-000066 · wf-form4_155735553752507.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,123,698 F1 · kind: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $2.7200-$2.7690, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 02, 2019 Filed Jan 7, 2019 17:12 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock | 566,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001305773-19-000008 · wf-form4_154689912032201.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,149,175 Read SEC document |
| December 04, 2018 Filed Dec 7, 2018 09:19 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 2,706 | $0.69 | $1,853.61 |
DisclosureSEC source: 0001305773-18-000098 · wf-form4_154419236654470.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582,481 F1 · kind: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $0.6051-$0.6890, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| August 08, 2018 Filed Aug 10, 2018 16:34 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 7,618 | $0.91 | $6,932.38 |
DisclosureSEC source: 0001305773-18-000077 · wf-form4_153393322911999.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 585,187 F1 · kind: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. Read SEC document |
| May 16, 2018 Filed May 18, 2018 18:33 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 7,638 | $1.30 | $9,953.84 |
DisclosureSEC source: 0001305773-18-000058 · wf-form4_152668275617143.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 592,805 F1 · kind: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.3000-$1.3723, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 07, 2018 Filed May 9, 2018 17:08 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock | 331,984 | $0.00 | $0.00 |
DisclosureSEC source: 0001305773-18-000040 · wf-form4_152590007515187.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,443 Read SEC document |
| December 19, 2017 Filed Dec 20, 2017 21:46 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 16,548 | $2.27 | $37,593.75 |
DisclosureSEC source: 0001305773-17-000141 · wf-form4_151382436326512.xml · nonDerivative · entry 2 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,459 F1 · kind: Represents the automatic sale of stock to cover the tax liability associated with the vesting of a Restricted Stock Award. F2 · price: The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $2.27-$2.2952, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 18, 2017 Filed Dec 20, 2017 21:46 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock | 48,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001305773-17-000141 · wf-form4_151382436326512.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,007 Read SEC document |
| December 05, 2017 Filed Dec 6, 2017 18:49 UTC | Conformis Inc CFMS · Entity 109987 | SaleCommon Stock | 4,189 | $2.68 | $11,226.52 |
DisclosureSEC source: 0001305773-17-000132 · wf-form4_151260414728706.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,163 F1 · kind: This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person and represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of a restricted stock award. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 08, 2017 Filed Aug 10, 2017 19:24 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001305773-17-000110 · wf-form4_150240747253626.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,352 Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:59 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock · Derivative | 190,114 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001305773-17-000080 · wf-form4_149506912634524.xml · derivative · entry 2 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 190,114 shares Expires 2027-05-15 F1 · derivative.exercise_date: Stock options vest ratably on a monthly basis for a period of 48 months beginning on the Grant Date. Read SEC document |
| May 15, 2017 Filed May 17, 2017 20:59 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock | 95,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001305773-17-000080 · wf-form4_149506912634524.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,352 Read SEC document |
| December 02, 2016 Filed Jan 9, 2017 21:02 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock · Derivative | 179,178 | $0.00 Strike: $8.78 | $0.00 |
DisclosureSEC source: 0001305773-17-000012 · wf-form4_148401373286893.xml · derivative · entry 2 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,178 Underlying: Common Stock · 179,178 shares Expires 2026-12-02 F1 · derivative.exercise_date: This option was granted on December 2, 2016 and vests over four years, with 25% of the shares underlying the option vesting on December 2, 2017 and 2.0833% of the shares underlying the option vesting monthly thereafter. Read SEC document |
| December 02, 2016 Filed Jan 9, 2017 21:02 UTC | Conformis Inc CFMS · Entity 109987 | GrantCommon Stock | 44,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001305773-17-000012 · wf-form4_148401373286893.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,750 Read SEC document |
| October 07, 2016 Filed Oct 11, 2016 20:18 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 272 | $83.05 | $22,589.60 |
DisclosureSEC source: 0001209191-16-145558 · doc4.xml · nonDerivative · entry 1 Augusti Mark A · CIK 0001481783 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,962 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.